scholarly journals Determination of spectral markers of cytotoxicity and genotoxicity using in vitro Raman microspectroscopy: cellular responses to polyamidoamine dendrimer exposure

The Analyst ◽  
2017 ◽  
Vol 142 (20) ◽  
pp. 3848-3856 ◽  
Author(s):  
Esen Efeoglu ◽  
Alan Casey ◽  
Hugh J. Byrne

Raman microspectroscopy as anin vitrolabel-free, high content screening technique to determine spectral markers of cytogenotoxicity.

The Analyst ◽  
2017 ◽  
Vol 142 (18) ◽  
pp. 3500-3513 ◽  
Author(s):  
Esen Efeoglu ◽  
Marcus A. Maher ◽  
Alan Casey ◽  
Hugh J. Byrne

Raman microspectroscopy as a ‘high content nanotoxicological screening technique’ with the aid of multivariate analysis, on non-cancerous and cancerous cell lines.


2013 ◽  
Vol 85 (19) ◽  
pp. 8996-9002 ◽  
Author(s):  
Stanislav O. Konorov ◽  
H. Georg Schulze ◽  
James M. Piret ◽  
Michael W. Blades ◽  
Robin F. B. Turner

2015 ◽  
Vol 7 (22) ◽  
pp. 9520-9528 ◽  
Author(s):  
S. Borel ◽  
E. A. Prikryl ◽  
N. H. Vuong ◽  
J. Jonkman ◽  
B. Vanderhyden ◽  
...  

Raman microspectroscopy in conjunction with multivariate statistical analysis is a powerful technique for label-free classification of live cells based on their molecular composition, which can be correlated to variations in protein, DNA/RNA, and lipid macromolecules.


The Analyst ◽  
2015 ◽  
Vol 140 (7) ◽  
pp. 2107-2113 ◽  
Author(s):  
Beata Brozek-Pluska ◽  
Monika Kopec ◽  
Izabela Niedzwiecka ◽  
Alina Morawiec-Sztandera

The applications of optical spectroscopic methods in cancer detection open new possibilities in oncological diagnostics.


Planta Medica ◽  
2010 ◽  
Vol 76 (12) ◽  
Author(s):  
W Jülich ◽  
J Pörksen ◽  
H Welzel ◽  
U Lindequist
Keyword(s):  

Planta Medica ◽  
2013 ◽  
Vol 79 (13) ◽  
Author(s):  
GN Ndlovu ◽  
G Fouche ◽  
W Cordier ◽  
V Steenkamp ◽  
M Tselanyane

1987 ◽  
Vol 26 (01) ◽  
pp. 1-6 ◽  
Author(s):  
S. Selvaraj ◽  
M. R. Suresh ◽  
G. McLean ◽  
D. Willans ◽  
C. Turner ◽  
...  

The role of glycoconjugates in tumor cell differentiation has been well documented. We have examined the expression of the two anomers of the Thomsen-Friedenreich antigen on the surface of human, canine and murine tumor cell membranes both in vitro and in vivo. This has been accomplished through the synthesis of the disaccharide terminal residues in both a and ß configuration. Both entities were used to generate murine monoclonal antibodies which recognized the carbohydrate determinants. The determination of fine specificities of these antibodies was effected by means of cellular uptake, immunohistopathology and immunoscintigraphy. Examination of pathological specimens of human and canine tumor tissue indicated that the expressed antigen was in the β configuration. More than 89% of all human carcinomas tested expressed the antigen in the above anomeric form. The combination of synthetic antigens and monoclonal antibodies raised specifically against them provide us with invaluable tools for the study of tumor marker expression in humans and their respective animal tumor models.


Sign in / Sign up

Export Citation Format

Share Document